As of July, 2017, 33 US states and Puetro Rico have enacted laws concerning biosimilar substitution.
As of July, 2017, 33 US states and Puetro Rico have enacted laws concerning biosimilar substitution. View the infographic here, or read more about the variation in state legislation.
Where clinical, regulatory, and economic perspectives converge—sign up for Center for Biosimilars® emails to get expert insights on emerging treatment paradigms, biosimilar policy, and real-world outcomes that shape patient care.